| 000 | 01576 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514042405.0 | ||
| 264 | 0 | _c20030507 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a1619-7070 | ||
| 024 | 7 |
_a10.1007/s00259-002-0868-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoka, D | |
| 245 | 0 | 0 |
_aRadioiodine therapy and thyrostatic drugs and iodine. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cAug 2002 |
||
| 300 |
_aS486-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntithyroid Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarbimazole _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDose-Response Relationship, Radiation |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aGraves Disease _xdrug therapy |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthyroidism _xdrug therapy |
| 650 | 0 | 4 |
_aIodine _xpharmacokinetics |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xpharmacokinetics |
| 650 | 0 | 4 |
_aMethimazole _xtherapeutic use |
| 650 | 0 | 4 |
_aPropylthiouracil _xtherapeutic use |
| 650 | 0 | 4 |
_aRadiation-Protective Agents _xpharmacology |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 700 | 1 | _aDietlein, M | |
| 700 | 1 | _aSchicha, H | |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 29 Suppl 2 _gp. S486-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-002-0868-4 _zAvailable from publisher's website |
| 999 |
_c12074225 _d12074225 |
||